Recent studies have demonstrated that a significantly lower level of CD28 surface expression on T cells was detected in diabetic rats, children with T1D, cell leukaemia, chronic lymphocytic leukaemia and colorectal cancer [36-38]. The gene discussed is CD28; the disease is B-cell chronic lymphocytic leukemia.